المؤلفون: Debets DO; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, 3584 CH Utrecht, the Netherlands., de Graaf EL; Pepscope B.V, Nieuwe Kanaal 7, 6709 PA Wageningen, the Netherlands., Liefaard MC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Medical Oncology, University of Amsterdam, Amsterdam, the Netherlands., Lips EH; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Ressa A; Pepscope B.V, Nieuwe Kanaal 7, 6709 PA Wageningen, the Netherlands., Altelaar M; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, Utrecht, 3584 CH Utrecht, the Netherlands.

المصدر: IScience [iScience] 2024 Apr 30; Vol. 27 (6), pp. 109858. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101724038 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-0042 (Electronic) Linking ISSN: 25890042 NLM ISO Abbreviation: iScience Subsets: PubMed not MEDLINE

المؤلفون: Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Voort A; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Seijen M; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Thijssen B; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Oncode Institute, Utrecht, The Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vonk S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Core Facility Molecular Pathology & Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mittempergher L; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Bhaskaran R; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., van Leeuwen-Stok AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Salgado R; Department of Pathology, GZA-ZNA Hospitals, Wilrijk, Antwerp, Belgium., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. g.sonke@nki.nl.

المصدر: NPJ breast cancer [NPJ Breast Cancer] 2024 Apr 18; Vol. 10 (1), pp. 29. Date of Electronic Publication: 2024 Apr 18.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

المؤلفون: Debets DO; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, 3584 Utrecht, the Netherlands., Stecker KE; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, 3584 Utrecht, the Netherlands., Piskopou A; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, 3584 Utrecht, the Netherlands., Liefaard MC; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wesseling J; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, University of Amsterdam, Amsterdam, the Netherlands., Lips EH; Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Altelaar M; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, University of Utrecht, 3584 Utrecht, the Netherlands. Electronic address: m.altelaar@uu.nl.

المصدر: Cell reports. Medicine [Cell Rep Med] 2023 Oct 17; Vol. 4 (10), pp. 101203. Date of Electronic Publication: 2023 Oct 03.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/metabolism, Humans ; Female ; Receptor, ErbB-2/genetics ; Receptor, ErbB-2/metabolism ; Proteomics ; Biomarkers, Tumor/genetics ; Biomarkers, Tumor/metabolism ; Neoadjuvant Therapy ; Biopsy, Needle

المؤلفون: Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Moore KS; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mulder L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Broek D; Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Wessels LFA; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of EEMCS, Delft University of Technology, Delft, The Netherlands., Rookus M; Department of Psychosocial and Epidemiology Research, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. e.lips@nki.nl.

المصدر: British journal of cancer [Br J Cancer] 2023 Sep; Vol. 129 (4), pp. 734.

نوع المنشور: Published Erratum

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: PubMed not MEDLINE; MEDLINE

المؤلفون: Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van der Voort A; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Ramshorst MS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sanders J; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Vonk S; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Core Facility Molecular Pathology and Biobanking, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Horlings HM; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Enschede, The Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., van Leeuwen AE; Dutch Breast Cancer Research Group, BOOG Study Center, Amsterdam, The Netherlands., Kleijn M; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Mittempergher L; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Kuilman MM; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Glas AM; Department of Research and Development, Agendia NV, Amsterdam, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Sonke GS; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. g.sonke@nki.nl.

المصدر: Breast cancer research : BCR [Breast Cancer Res] 2023 Jun 19; Vol. 25 (1), pp. 71. Date of Electronic Publication: 2023 Jun 19.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: BioMed Central Ltd Country of Publication: England NLM ID: 100927353 Publication Model: Electronic Cited Medium: Internet ISSN: 1465-542X (Electronic) Linking ISSN: 14655411 NLM ISO Abbreviation: Breast Cancer Res Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/drug therapy , Breast Neoplasms*/genetics , Breast Neoplasms*/pathology, Humans ; Female ; Neoadjuvant Therapy ; Receptor, ErbB-2/metabolism ; Trastuzumab/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects

المؤلفون: Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Moore KS; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Mulder L; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Broek D; Department of Clinical Chemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, the Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Wessels LFA; Division of Molecular Carcinogenesis, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of EEMCS, Delft University of Technology, Delft, The Netherlands., Rookus M; Department of Psychosocial and Epidemiology Research, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. e.lips@nki.nl.

المصدر: British journal of cancer [Br J Cancer] 2023 Apr; Vol. 128 (8), pp. 1572-1581. Date of Electronic Publication: 2023 Feb 10.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/diagnosis , Breast Neoplasms*/genetics, Humans ; Female ; Blood Platelets ; Reproducibility of Results ; Support Vector Machine

المؤلفون: van der Voort A; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Liefaard MC; Department of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Ramshorst MS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Werkhoven E; Department of Biometrics, Netherlands Cancer Institute, Amsterdam, the Netherlands., Sanders J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Wesseling J; Department of Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Scholten A; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Vrancken Peeters MJTFD; Department of Surgical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; University of Amsterdam, the Netherlands., de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands., Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organization, Utrecht, the Netherlands; Department of Health Technology and Services Research (HTSR), University of Twente, Enschede, the Netherlands., Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands; University of Amsterdam, the Netherlands. Electronic address: g.sonke@nki.nl.

المصدر: Breast (Edinburgh, Scotland) [Breast] 2022 Oct; Vol. 65, pp. 110-115. Date of Electronic Publication: 2022 Jul 13.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 9213011 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-3080 (Electronic) Linking ISSN: 09609776 NLM ISO Abbreviation: Breast Subsets: MEDLINE

مواضيع طبية MeSH: Breast Neoplasms*/pathology , Neoadjuvant Therapy*/methods, Antibodies, Monoclonal, Humanized ; Antineoplastic Combined Chemotherapy Protocols ; Female ; Humans ; Receptor, ErbB-2/analysis ; Trastuzumab

المؤلفون: Liefaard MC; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Lips EH; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Wesseling J; Division of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Leiden, The Netherlands., Hylton NM; Department of Radiology and Biomedical Imaging, University of California, San Francisco, CA., Lou B; Digital Technology and Innovation, Siemens Healthineers, Princeton, NJ., Mansi T; Digital Technology and Innovation, Siemens Healthineers, Princeton, NJ., Pusztai L; Yale Cancer Center, Yale School of Medicine, New Haven, CT.

المصدر: American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting [Am Soc Clin Oncol Educ Book] 2021 Mar; Vol. 41, pp. 1-12.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 101233985 Publication Model: Print Cited Medium: Internet ISSN: 1548-8756 (Electronic) Linking ISSN: 15488748 NLM ISO Abbreviation: Am Soc Clin Oncol Educ Book Subsets: MEDLINE

مواضيع طبية MeSH: Neoplasms*/diagnosis , Neoplasms*/epidemiology , Neoplasms*/therapy, Humans ; Prognosis ; Risk ; Technology

المؤلفون: Rontogianni S; 1Biomolecular Mass Spectrometry and Proteomics Group, Utrecht Institute for Pharmaceutical Science, Utrecht University, Utrecht, The Netherlands.; Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands., Synadaki E; 1Biomolecular Mass Spectrometry and Proteomics Group, Utrecht Institute for Pharmaceutical Science, Utrecht University, Utrecht, The Netherlands.; Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands., Li B; 1Biomolecular Mass Spectrometry and Proteomics Group, Utrecht Institute for Pharmaceutical Science, Utrecht University, Utrecht, The Netherlands.; Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands., Liefaard MC; 3Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Lips EH; 3Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Wesseling J; 3Division of Molecular Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.; 4Department of Pathology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Wu W; 1Biomolecular Mass Spectrometry and Proteomics Group, Utrecht Institute for Pharmaceutical Science, Utrecht University, Utrecht, The Netherlands.; Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands., Altelaar M; 1Biomolecular Mass Spectrometry and Proteomics Group, Utrecht Institute for Pharmaceutical Science, Utrecht University, Utrecht, The Netherlands.; Netherlands Proteomics Center, Padualaan 8, 3584 CH Utrecht, The Netherlands.; 5Mass Spectrometry and Proteomics Facility, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.

المصدر: Communications biology [Commun Biol] 2019 Sep 03; Vol. 2, pp. 325. Date of Electronic Publication: 2019 Sep 03 (Print Publication: 2019).

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: eCollection Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol

مواضيع طبية MeSH: Breast Neoplasms/*classification , Breast Neoplasms/*metabolism , Extracellular Vesicles/*metabolism , Proteomics/*methods, Animals ; Biomarkers, Tumor/metabolism ; Breast Neoplasms/blood ; Breast Neoplasms/ultrastructure ; Cattle ; Cell Line, Tumor ; Extracellular Vesicles/ultrastructure ; Female ; Humans ; Neoplasm Proteins/metabolism ; Phosphoproteins/metabolism ; Principal Component Analysis ; Proteome/metabolism

المؤلفون: Liefaard MC; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands; Netherlands Institute for Health Sciences, Rotterdam, the Netherlands., Ligthart S; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands., Vitezova A; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands., Hofman A; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands., Uitterlinden AG; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Kiefte-de Jong JC; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands., Franco OH; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands., Zillikens MC; Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands., Dehghan A; Department of Epidemiology, Erasmus University Medical Center, Rotterdam, the Netherlands.

المصدر: PloS one [PLoS One] 2015 Jul 06; Vol. 10 (7), pp. e0131740. Date of Electronic Publication: 2015 Jul 06 (Print Publication: 2015).

نوع المنشور: Journal Article; Observational Study; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE

مواضيع طبية MeSH: C-Reactive Protein/*metabolism , Vitamin D/*blood , Vitamin D Deficiency/*blood, Aged ; Aged, 80 and over ; Cohort Studies ; Female ; Genotype ; Humans ; Linear Models ; Male ; Mendelian Randomization Analysis ; Middle Aged ; Vitamin D Deficiency/genetics